International Journal of Scientific and Research Publications

Home
About Us
Editorial Board

Online Publication

Log In
New User?
       Register Now!
Forgot Password?
       Email Password!


Call For Papers

Call for Research Paper

Authors

Online Submission
Paper Submission Guidelines
Online Publication Charge
Print Publication Charge
How to publish research paper
Publication Certificate
Research Catalogue
Resources
FAQs

Reviewer

Join Reviewer Panel
Reviewer Guidelines

IJSRP Publications

E-Journal
Print Journal

Downloads

IJSRP Paper Format
Instructions

Contact Us

Feedback Form
Contact Us
Site Map

IJSRP, Volume 9, Issue 4, April 2019 Edition [ISSN 2250-3153]



      Hewa Kirindage Neranja Sandamini

Abstract: Hepatocellular Carcinoma is the most common liver malignancy in the world and accounts for the most number of cancer related deaths worldwide. Larger incidences of HCC cases are reported from developing countries and much lesser in developed countries. According to many studies men are at more risk of getting HCC than females. Hepatitis B virus remains as the most important risk factor while Hepatitis C virus, alcoholism, diabetes mellitus and obesity play a major role in HCC. Cirrhosis remains as an additional important risk factor specially in the United States.

[Reference this Paper]   [BACK]

Ooops! It appears you don't have a PDF plugin for this barrPostingser. you can click here to download the PDF file.

Reference this Research Paper (copy & paste below code):

Hewa Kirindage Neranja Sandamini (2019); Hepatocellular Carcinoma Preventive Vaccines and Clinical Trials; International Journal of Scientific and Research Publications (IJSRP) 9(4) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.9.04.2019.p8859

IJSRP PUBLICATIONS

Home

About Us
Editorial Board
Call for Paper

Call for Research Paper
Paper Status
IJSRP Paper Format
Join Us

Download e-journal
Join Forum
Invite Friends
Subscribe
Get Social with Us!



Copyright © 2011-2016, IJSRP Inc., All rights reserved.